Association between diabetes and subsequent malignancy risk among older breast cancer survivors
Menée à partir de données des registres américains des cancers portant sur 133 324 femmes âgées ayant survécu à un cancer du sein (âge : 66-84 ans ; durée médiane de suivi : 4,3 ans), cette étude analyse l'association entre un diabète et le risque de second cancer (10 452 cas)
Type II diabetes is associated with cancer risk in the general population but has not been well-studied as a risk factor for subsequent malignancies among cancer survivors. We investigated the association between diabetes and subsequent cancer risk among older (66-84 years), one-year breast cancer survivors within the linked Surveillance Epidemiology and End Results (SEER)-Medicare database using Cox regression analyses to quantify hazard ratios (HR) and corresponding 95% confidence intervals (95%CI). Among 133,324 women, 29.3% were diagnosed with diabetes prior- or concurrent to their breast cancer diagnosis, and 10,452 women developed subsequent malignancies over a median follow-up of 4.3 years. Diabetes was statistically significantly associated with liver (HR = 2.35, 95%CI=1.48-3.74), brain (HR = 1.94, 95%CI=1.26-2.96), and thyroid cancer risks (HR = 1.38, 95%CI=1.01-1.89). Future studies are needed to better understand the spectrum of subsequent cancers associated with diabetes and the role of diabetes medications in modifying subsequent cancer risk, alone or in combination with cancer treatments.
JNCI Cancer Spectrum 2023